ANI Pharmaceuticals ( (ANIP) ) has issued an update.
ANI Pharmaceuticals, Inc. has filed a Form 8-K with the SEC, indicating a recent event of significance for the company. This filing could potentially impact the company’s operations and market positioning, although specific details on the implications for stakeholders are not provided in the release.
More about ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. is a company based in Baudette, Minnesota, operating within the pharmaceutical industry. The company is primarily focused on the development, manufacturing, and marketing of generic and specialty pharmaceutical products.
YTD Price Performance: -1.55%
Average Trading Volume: 230,358
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.15B
For an in-depth examination of ANIP stock, go to TipRanks’ Stock Analysis page.